跳至主要内容
临床试验/NCT00971399
NCT00971399已完成3 期

Phase III Prospective Randomized Trial Comparing Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting in the Treatment of Gastrointestinal Cancer

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
172
试验地点
1
主要终点
complete response of RINV (no vomiting and no rescue medication)

研究概览

简要总结

The purpose of this study is:

  1. To compare prophylactic effect of ondansetron versus ramosetron on radiotherapy induced nausea and vomiting in the treatment of gastrointestinal cancer.
  2. To verify an improvement of 20% in complete response rate in term of radiotherapy induced nausea and vomiting (from 60% with ondansetron to 80% with ramosetron).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • AJCC 1-3 staged gastrointestinal cancer patient
  • patient undergoing radiotherapy as treatment
  • age 20 yr and higher

排除标准

  • age < 20
  • patient experiencing nausea or vomiting prior to accrual
  • patient under antiemetic medication
  • patient under steroid medication (topical or inhalant steroid application are exceptional)
  • patient under opioid medication

研究组 & 干预措施

RMS

Experimental

ramosetron 0.1mg q.d. SL on D1-5

干预措施: ramosetron (Drug)

ODS

Active Comparator

ondansetron 8mg, b.i.d SL on D1-5

干预措施: ondansetron (Drug)

结局指标

主要结局

complete response of RINV (no vomiting and no rescue medication)

时间窗: 4 weeks after medication

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Ramosetron Versus Ondansetron for Radiotherapy... | 临床试验